Short- and long-term outcome after PTCA in patients with stable and unstable angina

H J Rupprecht1, R Brennecke, M Kottmeyer

  • 1II. Medical Clinic, Johannes Gutenberg-University, Mainz, F.R.G.

European Heart Journal
|November 1, 1990
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) in unstable angina patients has higher acute complication risks. However, long-term outcomes show stable angina patients experience better quality of life post-PTCA.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Outcomes Research

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for managing coronary artery disease.
  • Differentiating outcomes between stable and unstable angina patients undergoing PTCA is crucial for treatment planning.

Purpose of the Study:

  • To compare the acute and long-term outcomes of PTCA in patients with stable versus unstable angina.
  • To assess the rates of major adverse cardiac events, mortality, and quality of life following PTCA in these patient groups.

Main Methods:

  • A prospective study involving 406 patients with stable angina and 202 with unstable angina undergoing attempted PTCA.
  • Follow-up data collected at acute, 12-month, and 36-month intervals to track cardiac events, mortality, and treatment status.

Main Results:

  • Unstable angina patients had significantly higher rates of acute complications (6.4% vs 1.5%) and early cardiac events (10.4% vs 1.7%) within the first week post-PTCA.
  • At 36 months, while long-term event rates showed no significant difference, cumulative myocardial infarction (3.7% vs 9.4%), mortality (3.0% vs 6.4%), and repeat PTCA (8.1% vs 19.3%) were lower in stable angina patients.
  • Stable angina patients reported a better quality of life, with 74% asymptomatic compared to 60% of unstable patients, and a lower need for antianginal treatment (45% vs 28%).

Conclusions:

  • PTCA in unstable angina is associated with a markedly enhanced risk of acute complications and early cardiac events.
  • Despite similar long-term event rates, patients with stable angina achieve a better quality of life post-PTCA, characterized by fewer symptoms and reduced medical treatment needs.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...